DVA · 8-K · 20260804PR000105

Market Demand Trends

DAVITA INC. · 2026-08-04 · Importance 25 · Surprise 32

U.S. dialysis treatments totaled 7,226,600 in the second quarter of 2026, averaging 92,649 treatments per day. Average daily treatments increased 1.09% sequentially from the first quarter, while normalized non-acquired treatment growth was 0.3% year over year. DaVita served approximately 298,500 patients through 2,671 U.S. outpatient dialysis centers. Revenue per treatment was $415.87 in the quarter, compared with $402.38 year to date in 2025, with changes primarily reflecting payer mix, annual rate increases, and normal fluctuations.

Key facts

• Average treatments per day increased 1.09% compared to the first quarter of 2026. source
• Normalized non-acquired treatment growth in Q2 2026 compared to Q2 2025 was 0.3%. source
• Number of normalized treatment days for Q2 2026 was 78.0 and normalized treatments per day average was 92,649 (per normalized day year-over-year change 0.6%). source
• Total U.S. dialysis treatments for the second quarter of 2026 were 7,226,600 (average of 92,649 treatments per day). source
• As of June 30, 2026, DaVita provided dialysis services to approximately 298,500 patients at 3,266 outpatient dialysis centers. source
• Of the 3,266 outpatient dialysis centers as of June 30, 2026, 2,671 centers were located in the United States and 595 centers were located in 14 countries outside of the United States. source